dbACP: A Comprehensive Database of Anti-Cancer Peptides

12 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp04385 MAC1/16 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay HeLa Cervical cancer IC50 : 32 ± 2 µM
dbacp04386 MAC1/16 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp04387 MAC1/16 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay CCRF-CEM Leukemia cancer IC50 : 70 µM
dbacp04388 MAC1/19 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay HeLa Cervical cancer IC50 : 21 ± 4 µM
dbacp04389 MAC1/19 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 68 ± 2 µM
dbacp04390 MAC1/19 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay CCRF-CEM Leukemia cancer IC50 : 43 ± 11 µM
dbacp04412 MAC1/4 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay HeLa Cervical cancer IC50 : 15 ± 5 µM
dbacp04413 MAC1/4 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 49 ± 9 µM
dbacp04414 MAC1/4 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay CCRF-CEM Leukemia cancer IC50 : 29 µM
dbacp04415 MAC1/6 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay HeLa Cervical cancer IC50 : 8 ± 2 µM
dbacp04416 MAC1/6 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 29 ± 3 µM
dbacp04417 MAC1/6 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay CCRF-CEM Leukemia cancer IC50 : 15 µM